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Abstract
Background: Local and national governments have implemented sector-specific policies to support economic
development through innovation, entrepreneurship and knowledge exchange. Supported by the Welsh
Government through the European Regional Development Fund, The Life Science Exchange® project was created
with the aim to increase interaction between stakeholders, to develop more effective knowledge exchange
mechanisms, and to stimulate the formation and maintenance of long-term collaborative relationships within the
Welsh life sciences ecosystem. The Life Science Exchange allowed participants to interact with other stakeholder
communities (clinical, academic, business, governmental), exchange perspectives and discover new opportunities.
Methods: Six sub-sector focus groups comprising over 200 senior stakeholders from academia, industry, the Welsh
Government and National Health Service were established. Over 18 months, each focus group provided input to
inform healthcare innovation policy and knowledge mapping exercises of their respective sub-sectors. Collaborative
projects identified during the focus groups and stakeholder engagement were further developed through sandpit
events and bespoke support.
Results: Each sub-sector focus group produced a report outlining the significant strengths and opportunities in
their respective areas of focus, made recommendations to overcome any ‘system failures’, and identified the
stakeholder groups which needed to take action. A second outcome was a stakeholder-driven knowledge mapping
exercise for each area of focus. Finally, the sandpit events and bespoke support resulted in participants generating
more than £1.66 million in grant funding and inward investment. This article outlines four separate outcomes from
the Life Science Exchange programme.
Conclusions: The Life Science Exchange process has resulted in a multitude of collaborations, projects, inward
investment opportunities and special interest group formations, in addition to securing over ten times its own costs
in funding for Wales. The Life Science Exchange model is a simple and straightforward mechanism for a regional or
national government to adapt and implement in order to improve innovation, skills, networks and knowledge
exchange.
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Background
Following the creation of the National Assembly for
Wales in 1998, the devolved Welsh Government (WG)
has instituted a string of innovation initiatives in an
attempt to invigorate the Welsh knowledge-based econ-
omy [1]. Nevertheless, despite receiving €3.9 billion
from European Structural Funds since 2000, the
Welsh economy has not improved its relative regional
disparities in income, wealth and opportunities when
compared to the United Kingdom as a whole and the
European Union [2].
Many strategies exist for carrying out knowledge ex-
change within the life science (LS) sector, yet there is a
lack of real-world application and evaluation of these in-
terventions in the context of academic engagement and
commercialisation [3]. Interventions aiming to improve
innovation “have met with varying levels of success, and,
interestingly, the most prominent approaches have been,
on the whole, less successful in Wales” [4]. Successes in
knowledge exchange activities include developing a
shared perspective, a plan for collaboration, and a range
of competencies [5].
In March 2012, the WG launched ‘Science for Wales’
[6], which set out a vision for where Wales should be
heading towards in the future. Three ‘Grand Challenge’
priority areas where Wales has a track record for excel-
lence were identified – ‘Life Sciences and Health’ being
one of these. It has been demonstrated that the LS sec-
tor can drive economic growth through ‘multiplier ef-
fects’ while also generating outputs which benefit society
and human health [7]. One of the key features of the LS
sector is that the collaboration between actors within
academia, industry, government and the National Health
Service (NHS) is particularly vital in the transfer of re-
search benefits to the public [8], which highlights the
importance of having a coherent framework, strategy
and policy which enables a thriving and sustainable LS
sector.
In September 2012, Swansea University Medical
School, in partnership with Cardiff University School of
Medicine and MediWales (a membership organisation
representing the LS industries of Wales), was tasked by
the WG to lead a knowledge exchange project (KEP) for
the Welsh Life Sciences and Health Grand Challenge
priority area called The Life Science Exchange® (or LSX).
The aim of the KEP was to increase interaction, develop
more effective knowledge exchange mechanisms, and
stimulate the formation and maintenance of long-
term collaborative relationships between industry and
academia.
The LSX was created as a process, not an organisation.
The vision was to create a mechanism which could con-
tinuously network all the stakeholders in Wales’ complex
LS ecosystem, in a way that allowed all to be involved.
The objective was to allow participants to interact with
other stakeholder communities (clinical, academic, busi-
ness, governmental), exchanging perspectives, and then
to support them by thinking about how Wales could im-
prove its performance. To provide focus, the work was
streamed into groups representing six of Wales’ specialist
areas (Diagnostics, eHealth, Medical Technology, Neuro-
science, Pharmaceuticals, and Regenerative Medicine),
which were selected to encompass the 12 LS areas priori-
tised in ‘Science for Wales’ policy.
The LSX project was designed with a goal of having
real world impact by supporting knowledge exchange,
policy development and collaborative projects. The aims
of this article are to articulate the methodologies used
by the LSX project, provide case studies of collaborative
projects identified and facilitated, and suggest how these
methodologies could be applied to other sectoral or
regional innovation systems.
Methods
Project overview
In line with best practice for knowledge management
projects [9], the LSX was overseen by a 17-member ex-
ecutive level steering group, comprising senior represen-
tatives of all stakeholder groups within the LS sector,
including academia, business, NHS Wales, WG and
third sector. The steering group convened quarterly over
the 18-month project to review progress made at the
focus groups and sandpit events. This group set the
strategy for the project, agreeing the areas in which de-
tailed research should be undertaken and the approach
to be taken by the project team. The work of the focus
groups and overall project management of the LSX was
undertaken by a small project team led by Professor
David Ford (see Fig. 1 for governance structure).
The LSX team comprised four staff members who pro-
vided overall project administration. Beyond planning,
organising and documenting the focus groups and sand-
pit events, the team provided bespoke support to LSX
members, including answering general inquiries regard-
ing the Welsh LS sector, making introductions, identify-
ing potential funding streams for collaborative projects,
assisting with grant applications and mapping of the
sector.
Given the aims, participant profiles and number of
participants as well as the relatively informal manner in
which discussions were held in these sessions, they were
not ‘focus groups’ as understood in qualitative research.
However, using the term ‘focus groups’ during and
after the project allowed both participants and non-
participants to quickly understand the activities that
were being undertaken. After the end of the LSX project,
some of these groups continued to meet and were more
properly referred to as ‘special interest groups’.
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Focus group recruitment
For each of the six specialist areas, a focus group was
established which aimed to include participants from
academia, industry, the WG, industrial networks and
NHS Wales. The project was funded with £181,553, of
which a majority (£139,424) was used to support the
staff organising the network communications and events
over the 18-month project. Once the staff were re-
cruited, they organised the branding, communications
and organisation of the first focus groups to be held.
The project team adopted an open and inclusive recruit-
ment process for the groups. The LSX was widely publi-
cised across the sector through established networks
(e.g. the National Institute of Social and Health Research
(NISCHR WG, now Health and Care Research Wales),
MediWales, NHS Health Boards), as well as by using
phone calls, e-mails, face-to-face meetings, social media
(e.g. LinkedIn and Twitter), leaflets and other network-
ing events. Additionally, the project team engaged in
sector research early into the project to target individ-
uals and organisations. The aim of this was to give all
the major sector stakeholders a fair chance to feed into
the process and to create groups that covered the inter-
ests of their specialist area as broadly as possible.
Focus group meetings
Each partner institution chaired two focus groups on a
quarterly basis. The purpose of the focus groups was to
act as the primary information gathering mechanism for
the project – primarily for developing policy recommen-
dations, performing a knowledge mapping exercise and
to promote collaborative working across the sector.
Members of the group were invited to regular, facilitated
discussions which captured stakeholder perspectives on
the strengths, weaknesses and opportunities for growth
across the LS sector. As well as taking this broad ap-
proach, specific focus groups also identified areas that
were unique to their field of interest.
Focus group attendance ranged from 10 to 40 stake-
holders, depending on the subsector, time of year, avail-
ability of the individuals, and geographic location of the
meeting. The focus groups were audio-recorded and
Fig. 1 Overview of the Life Science Exchange Funding, Governance and Operations
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transcribed, which provided a meticulous and robust
capturing method whilst allowing the project team to
focus on the discussions [10]. Similar to other policy-
making dialogue initiatives [11], Chatham House Rules
[12] were adopted in order to create an environment
where participants could speak freely. To ensure that the
LSX was as inclusive as possible, the project team also
engaged with some organisations and individuals on a
one-to-one basis. This option was offered to those who
wanted to participate in the process but did not neces-
sarily have the time or were geographically too far away
to engage through the focus group programme. In most
cases, the project team met these stakeholders in person
and discussed their perceptions of the LS sector. In
other cases, these discussions were held over the phone
or via email communication. The results of these
individual consultations were included into the data
which informed the final report writing and knowledge
mapping.
As the groups developed, the members were encour-
aged to consider which interventions might be put in
place to counteract sector weaknesses and capitalise on
existing strengths. An outcome of each focus group ses-
sion was a detailed record of the main conclusions that
had been agreed upon. These were used to inform the
final summary and subsector reports which were pro-
duced and circulated to WG’s Departments of Economy,
Science and Transport and of Health and Social Services
to consider for action.
For example, towards the end of the project, the
Regenerative Medicine focus group had the objective to
critically consider a strength, weakness, opportunity and
threat (SWOT) analysis of the regenerative medicine
landscape within Wales in order to produce a final rec-
ommendation for future development of this sector
across the academic, clinical and commercial Welsh re-
search landscape. A one-day focus group was organized
in Cardiff, bringing together representatives from across
the academic, clinical and commercial regenerative
medicine settings. To position thinking in a wider
United Kingdom context, initial presentations from
Innovate UK (formerly the Technology Strategy Board)
and Cell Therapy Catapult were received. This was
followed by a comprehensive update of the findings from
previous LSX Regenerative Medicine focus groups to
that point in the form of a SWOT analysis. Break out
groups then considered, in detail, shortfalls, problems
and solutions to stimulate the regenerative medicine sec-
tor in Wales. Feedback was collected and outputs pro-
duced for feedback to the LW KEP management board.
Knowledge mapping
The project team and stakeholders instigated a know-
ledge mapping exercise of their respective specialty areas
similar to the process described by Ebener et al. [13].
The project team engaged with higher education in-
stitutions, NHS contacts, industry contacts and the
WG to identify existing network maps and informa-
tion sources across the sector. These were then cross
referenced and validated to ensure they were current
additions to the knowledge mapping and not either
obsolete or a previous incarnation of another current
body. This served to inform businesses, academics
and other stakeholders of the institutional, community
and policy level networks.
Knowledge mapping was performed to provide a com-
prehensive visual map and database of expertise and fa-
cilities across academia, NHS and industry relevant to
each sub-sector within Wales. The mapping was under-
taken using a five-step process:
(1)Scoping: The knowledge mapping exercise began
by identifying potential data sources. The project
partners provided the LSX project team access to
a range of existing networks and also knowledge
bases of the sector. These included academic
centres and NHS research and development centres,
as well as Welsh government and industrial contacts.
The project team then cross referenced these
sources.
(2)Data collection: Information was gathered from the
data sources identified during scoping.
(3)Validation: Verification checks were made by team
members to ensure the information supplied was
accurate.
(4)Collation: The mapping was collated by both the
LSX project team and MediWales and presented in
both visual and database formats suitable for
searching by keyword.
(5)Gap analysis and review: The mapping was reviewed
by all the focus groups and also peer examined by
other academic, NHS, industrial networks and WG
Expertise Wales. Any gaps identified were addressed
to ensure the final mapping was reflective of the
sector.
The databases contained the names, affiliated institu-
tion, contact information, web-link and a short descrip-
tion of the individual/group expertise which could be
probed by keyword. Academic researcher and medical
team data was gathered from institute websites and
email contact with departmental leaders. Industry data
was compiled from MediWales’ Picture of Health [14],
online research and provided by focus group members.
General LS mapping provided data on WG and NISCHR
initiatives and teams within the sector, societies operat-
ing within Wales and identified awards of excellence
held by Welsh researchers.
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Sandpit events
The LSX engaged in a series of half-day sandpit events
which came about in response to opportunities raised
through the focus groups. Sandpits were originally de-
signed by the United Kingdom Research Councils as a
residential interactive workshop over 5 days involving
20–30 participants with a multidisciplinary mix of par-
ticipants to drive lateral thinking and radical approaches
to address research challenges [15]. The project team
assessed the range of opportunities that had been dis-
cussed at different stages of the project. Opportunities
which were most likely to interest a broad range of
stakeholders were considered as the focus for these half-
day sandpit events, which brought together a wider
audience from within the LS sector to feedback on the
findings of the focus groups and to input additional in-
formation and ideas. The main objective of these events
was to explore the possibilities for collaboration within
the event-specific opportunity area, as well as provide
the opportunity to have a more in-depth discussion
about key topics identified through the focus groups.
One example of the sandpit approach was focused on
the objective of ‘developing approaches to address un-
met needs in the area of managing chronic illness in
ageing’ within the Medical Technology group. This
event was a collaborative opportunity for leading aca-
demics, medical practitioners, service managers and
industry representatives in Wales to consider which
chronic diseases were not met within the NHS, where
expertise may exist in Wales and whether participants in
the sandpit were collaboratively equipped to enable a
technology to manage a met condition better or address
an unmet disease. The purpose of the first part of the
sandpit was to familiarise the group with the participants
on the day, their interests and background, and to define
a list of 10–12 illnesses that cannot be cured but can be
managed. The sandpit participants, in multidisciplinary
groups, then examined this list to consider the expertise,
experience and interests of the group to explore the op-
portunities to create collaborative proposal(s) for future
work. The final part of the sandpit was looking at scop-
ing initial collaborative ideas to address the objective of
the event and presenting them. The 40 participants were
drawn from across academia, industry and the NHS in
Wales and worked together in small multi-disciplinary
teams to maximise shared experience and knowledge
with the aim of generating creative solutions to known
issues through partnership working. By the end of the
day the participants explored their interests in collabor-
ating with a number of different groups/individuals with
the outcome of championing a single idea in a multi-
disciplinary group for onward funding proposal prepar-
ation and work. This sandpit led to the preparation of
funding proposals as an output.
Bespoke support results
The LSX project was able to support the Welsh LS sec-
tor by a range of mechanisms. These activities resulted
in a variety of outcomes for the sector, including detailed
policy recommendation reports delivered to the WG, a
codified mapping exercise of the LS sector in Wales, and
a range of collaborative projects.
Policy recommendations
A global overview of the opportunities identified in the
focus groups have been categorised into seven major
themes – each opportunity represented by a mark in
Table 1.
There was a recognised need for the discussions insti-
gated by the LSX to continue into the future. A number
of organisations expressed the desire to maintain the
momentum of their respective focus groups as special
interest groups.
The need for an accessible, cost-effective, up-to-date
source of sector-specific information relating to funding,
regulation, international trade and market intelligence
has been consistently expressed by the stakeholder focus
groups. This represents a significant and ongoing oppor-
tunity to provide Welsh LS organisations with a valuable
resource offered in addition to what is (and is not)
available.
The vital role that the Welsh NHS plays in providing
access to clinical expertise, facilities and, ultimately, as a
customer was widely expressed. While the relationship
between the NHS, academia and industry in Wales is
considered to be a significant national strength, there
was an expressed need to improve the evaluation and
adoption of new Welsh innovations when they can dem-
onstrate the opportunity for improved patient outcomes
and cost savings. Furthermore, academics and industry
expressed a strong desire for NHS Wales to increase its
level of engagement and receive clinical access for re-
search and development.
A key driver for future success is the ability to attract
and retain highly skilled individuals. Whilst the higher
education sector can focus on the development of train-
ing and, where feasible, accredited education in key
skills, retention requires growing industrial small and
medium enterprise clusters to provide sustainable em-
ployment opportunities across Wales. An all-Wales LS
skills group consisting of key academics has organised
discussions on delivering apprenticeships, continuous
professional development and degree-level training in
close collaboration with WG, NHS Wales and LS
industry.
Stakeholders felt that significant strengths in Wales’
LS research activity have been demonstrated across the
entire Welsh LS sector. They recommended that, in
order to build upon these strengths, further support
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through provision of facilities and resources was re-
quired to close specific gaps in research capacity.
The focus groups also made a strong case for ongoing
support for international trade and promotion. Most LS
sector products occupy global markets and numerous
Welsh companies sell the majority of their products out-
side of Wales. To support this activity, focus groups re-
quested continued or additional support to attend trade
shows and conferences.
Knowledge mapping
A second outcome was a stakeholder-driven knowledge
mapping exercise for each area of focus. Many examples
of duplication of activity as well as underutilisation of re-
sources were identified. In some instances, businesses
were paying to utilise resources outside of Wales due to
a lack of awareness of resources existing locally.
The outputs of the knowledge mapping exercises for
each focus group were represented in various formats,
including a database of key figures, lists of key organisa-
tions, process diagrams, organisational charts and maps.
For example, the eHealth focus group produced a data-
base outlining key individuals in WG, learned societies,
industry, academic departments, and research facilities.
This database included institution and/or department
names, named individuals, websites and contact details
which were publicly available. The eHealth group also
created a set of PowerPoint slides containing organisa-
tional charts of academic, WG, NHS Wales and third
sector organisations. Similarly, the Regenerative Medicine
focus group produced a database containing academic,
commercial and NHS Wales networks and facilities. As
the group was research-focused, they also created an or-
ganisational chart of regenerative medicine research by
technology type (stem cells, disease process and bio-
markers, cell signalling, etc.).
Funding secured
Although funded with only £181,553, the LSX project
was able to secure over £1.66 million pounds of project
funding for its participants through the sandpit events
and bespoke support:
 £800,000: Innovate UK, Small Business Research
Initiative (SBRI), Abertawe Bro Morgannwg
University Health Board (ABMUHB)
 £772,208: WG, Health Technology and Telehealth
Fund AliveCore, ABMUHB
 £50,000: Welsh Government Academic Expertise
For Business Digital Health Conference
 £40,000: Betsi Cadwallder SBRI SymlConnect
Case studies
Beyond quantitative financial outputs, a range of case
studies have been provided below in order to describe the
types of outcomes the LSX was able to accomplish beyond
the focus groups and knowledge mapping. Such outcomes
included the piloting of new procurement mechanisms,
securing grant funding for a commercial clinical trial, es-
tablishment of new special interest groups, and the forma-
tion of an all-Wales LS Skills Group, among others.
New procurement mechanisms
One of the projects the eHealth group identified was the
3-year SBRI, funded by Innovate UK, which aims to
boost the research and development industry, increase
commercialisation of new technologies and create jobs
and wealth. A project to improve ABMUHB, in partner-
ship with Swansea University, has received £800,000
funding towards their £950,000 project to support health
services in Swansea, Bridgend and Neath Port Talbot
through the better use of patient records and data.
The SBRI project came about following discussions in
an eHealth focus group, which was led by a member
who had prior experience of undertaking SBRIs outside
of Wales. Also at that meeting was the manager from
the eHealth Industries Centre in Swansea University,
who subsequently identified the SBRI opportunity and
engaged with ABMUHB. ABMUHB identified a chal-
lenge and were extremely receptive and supportive of
Table 1 Summary of opportunities provided by each focus group. Each opportunity identified in each focus group is represented
by a single dot. For example, the Neuroscience focus group provided four separate recommendations relating to enhanced research
capacity
Opportunities Diagnostics eHealth Medical technology Neuroscience Pharmaceuticals Regenerative medicine
Establishment of new special interest groups • • • •
Mapping, sector knowledge and
communication
• • • •
NHS procurement and technology adoption • • • •
NHS engagement and clinical access • •• • • •
Growing a skilled and trained workforce • • • •
Enhanced research capacity • • •••• •
International conferences and marketing • • •
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the SBRI process. The eHealth group then discussed the
opportunity and many attended the two events hosted
by LSX with eHealth Industries Innovation Centre (ehi2)
and WG.
Two local companies were tasked with using patient
data to shape the future of patient care in the region.
They were the strongest candidates to emerge from the
feasibility phase of a 3-year SBRI launched in partner-
ship with ABMUHB and Swansea University’s Health
Informatics group. Together, these companies have
worked to help ABMUHB better understand the health
needs of patients, and predict how these could change.
This could support much more efficient use of re-
sources, and ultimately help improve public health ser-
vices; as well as the health and well-being of local
communities.
New commercial clinical trial
One funding source identified in the eHealth focus
group was the WG’s £9.5 million Health Technology and
Telehealth Fund. A United States-based company,
AliveCor, manufacture heart monitors that can be used
with most mobile technology. In January 2014, the WG
introduced AliveCor to the LSX project team, who pro-
vided bespoke support to form a collaborative project
between the company and eHealth focus group at-
tendees. Staff at Swansea University’s Joint Clinical
Research Facility are now working with Morriston
Hospital, the WG and AliveCor to trial the AliveCor sys-
tem, which converts iPhone and Android compatible
mobile devices into hand-held ECG machines that can
be used to monitor a person’s heart. This research is
funded by WG’s Health Technology and Telehealth
Fund. It is proposed that the AliveCor system will be
trialled in the clinic to identify patients with atrial fibril-
lation in the community to facilitate earlier diagnosis
and treatment and reduce the incidence of major ad-
verse cardiovascular events, notably stroke.
The LSX team continued to contribute to the project
by assisting with the governance, project management,
value creation and economic value sections of the
bid, as well as obtaining formal confirmation of sup-
port from the ABMUHB Research and Development
department. In April 2014, the £652,208 bid to the
Health Technology and Telehealth Fund was approved,
with AliveCor making an additional £120,000 inward in-
vestment into Wales.
New commercial special interest groups
MediWales was introduced to a range of pharmaceutical
stakeholders at a LSX pharmaceutical focus group event
in February 2014. Directly following these interactions,
MediWales facilitated a LSX pharmaceutical sandpit
event in June 2014. The event, hosted at the Norgine
factory in Hengoed, was attended by 23 delegates from
13 companies, universities and healthcare providers, all
of whom are involved in pharmaceutical research, drug
development, formulation, manufacture, packaging, trials
or distribution. As a result of the meeting the group
identified an opportunity to work together to deliver and
promote a full range of services to the pharmaceutical
sector. Under the brand name Clinical Trials Services
Wales, with ongoing support from MediWales, the new
special interest group will continue to meet regularly.
They are now developing a brand identity, mapping clin-
ical trials services in Wales against the pharmaceutical
route to market and developing marketing, promotional
material and a programme of activity for the coming
year.
The concept was driven by the idea that MediWales
members involved in the delivery of clinical trials can
meet international customer needs from ‘molecule to
market’ and together represent a significant global force.
Through collaboration, the interest group member orga-
nisations have identified the opportunity to (1) provide
a faster more streamlined service to their customers,
(2) to create new business opportunities, and (3) to de-
liver a complete clinical trials service and to support
their customers’ needs through a strong referral net-
work. Following this launch, the Members will work
together to deliver on a commitment to provide a
more integrated streamlined service, saving customers
time and money, and delivering the highest quality of
service. The Group will work together to extend each
organizations visibility on the world stage through pro-
motion at international events, press coverage and on-
line. Each individual organisation will act as a referral
point to all of the members of the Group.
This ‘sub-sector’ approach is now being rolled out to
create a medical technology and diagnostics special
interest group led by MediWales.
New all-Wales life sciences skills group
Within a diagnostics focus group, skills for the sector
were identified as an area where development was re-
quired. The LSX project team subsequently met with
representatives from Cogent, the Sector Skills Council for
Life Science, as well as WG’s Department for Education
and Skills and Department of Economy, Science and
Transport. There was a level of involvement from the
Sector Skills Council for Science, Engineering and
Manufacturing Technologies, University of South Wales
and the Regional Learning Partnership.
An all-Wales LS skills group organised discussions
on delivering apprenticeships, continuing professional
development and degree-level training in close collab-
oration with WG, NHS Wales and the LS industrial
sector. The group, now chaired by a representative from
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Swansea University Medical School, has been recognised
by the WG for its proposed work on the LS skills agenda
and aims to represent the needs of the growing sector in
this arena.
Discussion
The LSX project delivered extensive engagement with
the Welsh LS sector in order to provide authentic
insight into the strengths, challenges and opportunities
for Wales. The significant contribution made by repre-
sentatives from the Welsh LS academic, industrial and
clinical organisations has culminated in the final reports
of the LSX project.
Policy recommendations
Detailed conclusions have been made by each of the sec-
tor focus groups, with a number of common and unique
themes across all of them. Based on the varying outputs
of recommendations by each focus group, it is clear that
each of the specialties has different needs. The stake-
holders in the Neuroscience Group appeared to be more
active in earlier stage research and development and
recognised opportunities in enhancing Wales’ neurosci-
ence research capacity. Those that have more of an in-
dustrial base (e.g. eHealth, Diagnostics, Medical Devices
and Pharmaceuticals) focused their attention on NHS
engagement, procurement and technology adoption. All
of the summarised opportunities found in Table 1 were
discussed in each focus group; however, some were not
identified as a recommendation to address for their
respective specialty.
The detailed reports have been supplied to the WG’s
LS Sector Team to inform policy and strategy; however,
it is unclear just how effective these recommendations
will be until future policy is implemented. They were
also made available to key stakeholders by the WG upon
request. These recommendations provide the best op-
portunity for the sub-sector groups to progress their
work as they provide the unified view of the current
state of the Welsh LS sector and how it should be im-
proved in their areas of speciality. In current discussions
with stakeholders, these recommendations are being
used to inform research and funding applications, espe-
cially in the establishment of new special interest groups,
growing a skilled and trained workforce, and enhanced
research capacity (i.e. equipment and facilities).
Knowledge mapping
The value of the exercise is difficult to quantify, though
recipients of the mapping have utilised it to inform new
academic- and industry-based knowledge sources of
their own. It could be stated that the exercise provided a
clearer sector picture of a diverse range of mapping and
knowledge already in existence and therefore gave
organisations who received it an up to date and accurate
‘snapshot’ of the LS sector in Wales for others to build
on. In a fast moving sector this was as much as could be
expected as the accuracy and completeness of any map-
ping exercise lessens as time passes.
The knowledge mapping exercises were supplied to
the WG’s LS Sector Team to inform policy and strategy.
The maps were developed to cover four constituent areas,
those being academia, industry, NHS and Government
(including allied services such as MediWales). These maps
were then focused further on the theme (e.g. medical tech-
nology, regenerative medicine or eHealth) to provide a
snapshot of subsectors of LS in Wales. They were
made available to NISCHR, LSX participants, LS Hub
Wales and key stakeholders by the WG upon request.
MediWales has since utilised the mapping to inform
their ‘Picture of Health’ [14] interactive map of the
Welsh LS sector. NISCHR have utilised the mapping to
inform their 2015 service structure review and it has also
been utilised by the LS Hub. Academic use included
Swansea and Cardiff Universities.
Limitations
However successful, a major drawback of the LSX was
the short 18-month time frame and limited budget to
carry out its operations. The timeline and budget was
solely based on the project obtaining funds from the end
of the European Regional Development Fund structural
funds programme running from 2007 to 2014. Following
the end of the project, further actions were required to
ensure its legacy was exploited. The subsector focus
groups were able to codify their detailed reports and
mapping exercises by the end of the project. However,
without the project staff to organise the network after
the report submissions, there was very little that could
be done by the LSX support staff to ensure the policy
recommendations were addressed by the WG. Further-
more, it was difficult to resource collaborative projects
identified towards the end of the project, as there was a
risk of leaving them without support. If LSE had been
funded for a longer period of time or refunded after the
initial period, the project could have had more impact
on the LS sectoral policy in Wales. As a recommenda-
tion, sustainability and/or continuity planning should be
performed at the beginning of projects such as the LSX
in order to ensure that value in the personnel, networks
and project(s) are not lost between funding rounds.
Adaptation of LSX
The LSX was focused on supporting the LS sector in
Wales in a subsector approach. Notwithstanding this,
the framework could be applied to a very wide range of
other (sub)sectors and/or regions. Simply setting up a
knowledge exchange mechanism similar to the LSX
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would not necessarily result in successful or similar
outcomes – each sector and region has its own particu-
larities that would need to be considered. For example,
although two other KEPs were funded by the WG con-
currently to the LSX, they did not follow the same gov-
ernance and methods. Instead of holding focus groups,
the Materials and Advanced Engineering Knowledge
Exchange Strategy KEP determine the sector’s barriers
and opportunities compared to 30 companies outside
Wales. Through these methods, this KEP was able to
secure two Knowledge Transfer Partnerships valued at
£129,000, placed about £500,000 in collaborative grant
applications and created a range of Masters-level stu-
dentships with industry. The Low Carbon Energy and
Environment Network for Wales KEP used a mixture of
workshops, surveys and research to report on the major
barriers and opportunities for the low carbon energy and
environment sector in Wales; yet it is unclear how
successful their model was in producing collaborative
projects.
The implementation of a successful knowledge ex-
change programme requires a number of factors to be in
place. First and foremost, a relatively active sectoral
innovation system is needed to ensure enough stake-
holders can contribute to the process. Secondly, project
leaders need to have relatively established networks in
place to ensure effective and timely recruitment. Thirdly,
dedicated staff and an event budget are needed to ensure
the network is able to communicate, meet regularly and
synthesise their knowledge. Finally, in order for mean-
ingful and innovative collaborative projects to be sup-
ported beyond the conception stage, robust funding
mechanisms are required (e.g. Innovate UK or the
United Kingdom Research Councils).
Conclusions
The output of the LSX is a valuable body of intelligence
that represents the collective expertise of a wide range
of expert contributors. This work should serve to inform
future policy and planning across the sector and will
help to align support activities with the needs of com-
panies, universities and healthcare providers. Specific,
actionable recommendations have been provided in the
detailed reports provided by the LSX to the WG. Ultim-
ately, this work should be used to improve innovation,
health and wealth in Wales, as well as influence the de-
sign and implementation of knowledge exchange mecha-
nisms in other geographies and sectors.
There was a recognised need for the discussions insti-
gated by the LSX to continue into the future. In some
cases, specific challenges and opportunities need to be
crystallised into detailed proposals with specific objec-
tives, deliverables, budgets and time-scales. A number of
organisations have expressed the desire to maintain the
momentum of their respective focus groups as special
interest groups operating under the LSX brand or
unique branding (e.g. Clinical Trials Services Wales).
The LSX process succeeded in bringing together hun-
dreds of stakeholders in a sub-sectoral approach to the
Welsh National Innovation System. This has resulted in
a multitude of collaborations, projects, inward invest-
ment opportunities, and special interest group forma-
tions, in addition to leveraging over ten times its
funding for Wales. Processes such as the LSX can be
considered exemplars of best practice for knowledge ex-
change for other sectoral systems of innovation. The
LSX model is a simple and straightforward mechanism
for any regional government to adapt and implement
with the hopes of improving innovation, skills, networks
and knowledge exchange.
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